speb/financial-data huggingface dataset:
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Interest Expense: 161100000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 23600000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 161100000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 23600000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Interest Income: 516000000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 516000000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -128000000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Inventory: 9385400000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 9385400000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 47390800000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 47390800000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -4289200000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 298300000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 298300000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Investmentsin Joint Venturesat Cost: 0.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Joint Venturesat Cost: 0.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 0.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 2235800000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 2235800000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 394200000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 394200000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 394200000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 394200000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 0.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 0.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 511500000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 511500000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 18023700000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 18023700000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -32600000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 0.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Net Debt: 1087300000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 1087300000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -581400000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Net Income: 10560000000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Net Income: 2667000000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 10560000000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2667000000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 10560000000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2667000000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 10560000000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2667000000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 10560000000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2667000000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 13776500000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 10560000000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2667000000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Net Interest Income: 354900000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -23600000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -1112800000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 2094000000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 2094000000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 354900000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -23600000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 453700000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 21205100000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 21205100000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 54100000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 44855100000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 44855100000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 16700000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 16700000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 1885900000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1885900000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1179400000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1179400000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 511500000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 511500000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 64200000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 64200000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 16615600000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 3948400000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Normalized Income: 11285568900.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 2667000000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 5291900000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Operating Income: 13266000000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Operating Income: 7307400000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 54072600000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 14216400000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 124935624.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 124935624.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 2677300000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2677300000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 1190000000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1190000000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 32200000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 32200000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 415800000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 415800000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 635800000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 635800000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -358200000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 617700000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 617700000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 16700000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 16700000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 130500000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -3839400000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 8034400000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Other Payable: 1441300000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 1441300000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 18253700000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 18253700000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 230900000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 230900000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 5598500000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 5598500000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Other Special Charges: 18700000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Payables: 6896300000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 6896300000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 303900000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 303900000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 1299300000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1299300000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Pretax Income: 13776500000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 3471100000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -32600000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -26603700000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 3154000000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 3154000000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 12477000000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3048100000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 1731400000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 453700000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 88500000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 88500000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: 0.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 15100000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 15100000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 43780600000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 43780600000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 25490900000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 54100000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 4388900000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 6014600000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 124935624.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 124935624.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Special Income Charges: -18700000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 15300000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 45270900000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 45270900000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 44855100000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 44855100000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -221031100.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Tax Provision: 3216500000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 804100000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.23
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.23
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 1253700000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 1253700000.00
AJANTPHARM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -3589900000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 61548400000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 61548400000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 45270900000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 45270900000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 2601700000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 2601700000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 45270900000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 45270900000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Total Expenses: 40806600000.00
AJANTPHARM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 6909000000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 16277500000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 16277500000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 24194100000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 24194100000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2120000000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2120000000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 54900000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 54900000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -946600000.00
AJANTPHARM.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -946600000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Tradeand Other Payables Non Current: 18200000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 18200000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Work In Process: 645200000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 645200000.00
AJANTPHARM.NS balance_sheet (annual, 2026-03-31) — Working Capital: 23196800000.00
AJANTPHARM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 23196800000.00
AJAX.AS income_statement (annual, 2021-06-30) — +Operating Expense: 188415000.00
AJAX.AS income_statement (annual, 2021-06-30) — +Total Revenue: 108904000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Accounts Payable: 30171000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Accounts Receivable: 51736000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -31841000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Additional Paid In Capital: 101120000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Allowance For Doubtful Accounts Receivable: -1812000.00
AJAX.AS income_statement (annual, 2021-06-30) — Amortization: 61236000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Amortization Cash Flow: 733000.00
AJAX.AS income_statement (annual, 2021-06-30) — Basic Average Shares: 18333333.00
AJAX.AS income_statement (annual, 2021-06-30) — Basic EPS: -0.44
AJAX.AS cash_flow (annual, 2021-06-30) — Beginning Cash Position: 22496000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Buildings And Improvements: 178773000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Capital Expenditure: -3793000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Capital Lease Obligations: 146605000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Capital Stock: 8250000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 17713000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 41998000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Cash Financial: 17713000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Change In Inventory: -1614000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Change In Other Current Liabilities: 12738000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Change In Receivables: -2230000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Change In Working Capital: 8894000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Changes In Cash: -4974000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Common Stock: 8250000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Common Stock Equity: 221953000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Construction In Progress: 1721000.00
AJAX.AS income_statement (annual, 2021-06-30) — Cost Of Revenue: 14147000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Current Assets: 114852000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Current Capital Lease Obligation: 6591000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Current Debt: 0.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Current Debt And Capital Lease Obligation: 6591000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Current Liabilities: 89908000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Depreciation: 11404000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Depreciation And Amortization: 12137000.00
AJAX.AS income_statement (annual, 2021-06-30) — Depreciation And Amortization In Income Statement: 72640000.00
AJAX.AS income_statement (annual, 2021-06-30) — Depreciation Income Statement: 11404000.00
AJAX.AS income_statement (annual, 2021-06-30) — Diluted Average Shares: 18333333.00
AJAX.AS income_statement (annual, 2021-06-30) — Diluted EPS: -0.44
AJAX.AS income_statement (annual, 2021-06-30) — Diluted NI Availto Com Stockholders: -8057000.00
AJAX.AS income_statement (annual, 2021-06-30) — EBIT: -9558000.00
AJAX.AS income_statement (annual, 2021-06-30) — EBITDA: 63082000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Effect Of Exchange Rate Changes: 191000.00
AJAX.AS cash_flow (annual, 2021-06-30) — End Cash Position: 17713000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Financing Cash Flow: -7316000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Finished Goods: 5385000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Free Cash Flow: -17915000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Gain Loss On Sale Of Business: -1000.00
AJAX.AS income_statement (annual, 2021-06-30) — General And Administrative Expense: 14033000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Goodwill And Other Intangible Assets: 141564000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Gross Accounts Receivable: 53548000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Gross PPE: 195597000.00
AJAX.AS income_statement (annual, 2021-06-30) — Gross Profit: 94757000.00
AJAX.AS income_statement (annual, 2021-06-30) — Interest Expense: 2158000.00
AJAX.AS income_statement (annual, 2021-06-30) — Interest Expense Non Operating: 2158000.00
AJAX.AS income_statement (annual, 2021-06-30) — Interest Income: 151000.00
AJAX.AS income_statement (annual, 2021-06-30) — Interest Income Non Operating: 151000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Interest Paid Cfo: -2159000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Interest Received Cfo: 161000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Inventory: 5385000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Invested Capital: 221953000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Investing Cash Flow: 16464000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Long Term Capital Lease Obligation: 140014000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Long Term Debt: 0.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Long Term Debt And Capital Lease Obligation: 140014000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Long Term Debt Payments: -3000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Long Term Equity Investment: 4678000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Machinery Furniture Equipment: 2900000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Minority Interest: 0.00
AJAX.AS income_statement (annual, 2021-06-30) — Minority Interests: 48000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Net Business Purchase And Sale: -1006000.00
AJAX.AS income_statement (annual, 2021-06-30) — Net Income: -8057000.00
AJAX.AS income_statement (annual, 2021-06-30) — Net Income Common Stockholders: -8057000.00
AJAX.AS income_statement (annual, 2021-06-30) — Net Income Continuous Operations: -8105000.00
AJAX.AS income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: -8057000.00
AJAX.AS income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: -8057000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Net Income From Continuing Operations: -33154000.00
AJAX.AS income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: -8105000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Net Intangibles Purchase And Sale: -1794000.00
AJAX.AS income_statement (annual, 2021-06-30) — Net Interest Income: -2007000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Net Investment Purchase And Sale: 4630000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Net Issuance Payments Of Debt: -3000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Net Long Term Debt Issuance: -3000.00
AJAX.AS income_statement (annual, 2021-06-30) — Net Non Operating Interest Income Expense: -2007000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Net Other Investing Changes: 16629000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Net PPE: 163756000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Net PPE Purchase And Sale: -1995000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Net Tangible Assets: 80389000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Non Current Deferred Taxes Assets: 4006000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Non Current Deferred Taxes Liabilities: 19935000.00
AJAX.AS income_statement (annual, 2021-06-30) — Normalized EBITDA: 62836000.00
AJAX.AS income_statement (annual, 2021-06-30) — Normalized Income: -8227232.00
AJAX.AS cash_flow (annual, 2021-06-30) — Operating Cash Flow: -14122000.00
AJAX.AS income_statement (annual, 2021-06-30) — Operating Income: -93658000.00
AJAX.AS income_statement (annual, 2021-06-30) — Operating Revenue: 108904000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Ordinary Shares Number: 18333333.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Other Current Liabilities: 18946000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Other Intangible Assets: 141564000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Other Non Current Liabilities: 9902000.00
AJAX.AS income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 86067000.00
AJAX.AS income_statement (annual, 2021-06-30) — Other Operating Expenses: 18417000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Other Payable: 340000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Other Properties: 12203000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Other Receivables: 15733000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Other Short Term Investments: 24285000.00
AJAX.AS income_statement (annual, 2021-06-30) — Other Special Charges: -1000.00
AJAX.AS income_statement (annual, 2021-06-30) — Otherunder Preferred Stock Dividend: 0.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Payables: 40365000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 340000.00
AJAX.AS income_statement (annual, 2021-06-30) — Pretax Income: -11716000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Properties: 0.00
AJAX.AS cash_flow (annual, 2021-06-30) — Purchase Of Business: -1006000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Purchase Of Investment: 0.00
AJAX.AS cash_flow (annual, 2021-06-30) — Purchase Of PPE: -1999000.00
AJAX.AS income_statement (annual, 2021-06-30) — Reconciled Cost Of Revenue: 14147000.00
AJAX.AS income_statement (annual, 2021-06-30) — Reconciled Depreciation: 12137000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Repayment Of Debt: -3000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Retained Earnings: -8057000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Sale Of Intangibles: 0.00
AJAX.AS cash_flow (annual, 2021-06-30) — Sale Of Investment: 4630000.00
AJAX.AS cash_flow (annual, 2021-06-30) — Sale Of PPE: 4000.00
AJAX.AS income_statement (annual, 2021-06-30) — Selling General And Administration: 14033000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Share Issued: 18333333.00
AJAX.AS income_statement (annual, 2021-06-30) — Special Income Charges: 1000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Stockholders Equity: 221953000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Tangible Book Value: 80389000.00
AJAX.AS income_statement (annual, 2021-06-30) — Tax Effect Of Unusual Items: 75768.00
AJAX.AS income_statement (annual, 2021-06-30) — Tax Provision: -3611000.00
AJAX.AS income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.31
AJAX.AS cash_flow (annual, 2021-06-30) — Taxes Refund Paid: 0.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Total Assets: 503372000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Total Capitalization: 221953000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Total Debt: 146605000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 221953000.00
AJAX.AS income_statement (annual, 2021-06-30) — Total Expenses: 202562000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 281419000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Total Non Current Assets: 388520000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Total Non Current Liabilities Net Minority Interest: 191511000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Total Tax Payable: 10194000.00
AJAX.AS income_statement (annual, 2021-06-30) — Total Unusual Items: 246000.00
AJAX.AS income_statement (annual, 2021-06-30) — Total Unusual Items Excluding Goodwill: 246000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Tradeand Other Payables Non Current: 21660000.00
AJAX.AS balance_sheet (annual, 2021-06-30) — Working Capital: 24944000.00
AJAX.AS income_statement (annual, 2022-06-30) — +Operating Expense: 229987000.00
AJAX.AS income_statement (annual, 2022-06-30) — +Total Revenue: 184269000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Accounts Payable: 28754000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Accounts Receivable: 59545000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -34443000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Additional Paid In Capital: 101120000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Allowance For Doubtful Accounts Receivable: -4416000.00
AJAX.AS income_statement (annual, 2022-06-30) — Amortization: 57824000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Amortization Cash Flow: 753000.00
AJAX.AS income_statement (annual, 2022-06-30) — Basic Average Shares: 18333333.00
AJAX.AS income_statement (annual, 2022-06-30) — Basic EPS: -1.33
AJAX.AS cash_flow (annual, 2022-06-30) — Beginning Cash Position: 17713000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Buildings And Improvements: 177890000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Capital Expenditure: -3894000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 145989000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Capital Stock: 8250000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 20380000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 43012000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Cash Financial: 20380000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Change In Inventory: 1476000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Change In Other Current Liabilities: 1918000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Change In Receivables: -2320000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Change In Working Capital: 1074000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Changes In Cash: 2672000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Common Stock: 8250000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Common Stock Equity: 197636000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Construction In Progress: 3896000.00
AJAX.AS income_statement (annual, 2022-06-30) — Cost Of Revenue: 18930000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Current Assets: 121425000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 7507000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 7507000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Current Liabilities: 93771000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Depreciation: 11350000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Depreciation And Amortization: 12103000.00
AJAX.AS income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 69174000.00
AJAX.AS income_statement (annual, 2022-06-30) — Depreciation Income Statement: 11350000.00
AJAX.AS income_statement (annual, 2022-06-30) — Diluted Average Shares: 18333333.00
AJAX.AS income_statement (annual, 2022-06-30) — Diluted EPS: -1.33
AJAX.AS income_statement (annual, 2022-06-30) — Diluted NI Availto Com Stockholders: -24320000.00
AJAX.AS income_statement (annual, 2022-06-30) — EBIT: -28637000.00
AJAX.AS income_statement (annual, 2022-06-30) — EBITDA: 40537000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Effect Of Exchange Rate Changes: -5000.00
AJAX.AS cash_flow (annual, 2022-06-30) — End Cash Position: 20380000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Financing Cash Flow: -7615000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Finished Goods: 3909000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Free Cash Flow: -206000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Gain Loss On Sale Of Business: -4000.00
AJAX.AS income_statement (annual, 2022-06-30) — General And Administrative Expense: 24157000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 108283000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Gross Accounts Receivable: 63961000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Gross PPE: 197465000.00
AJAX.AS income_statement (annual, 2022-06-30) — Gross Profit: 165339000.00
AJAX.AS income_statement (annual, 2022-06-30) — Interest Expense: 3094000.00
AJAX.AS income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 3094000.00
AJAX.AS income_statement (annual, 2022-06-30) — Interest Income: 464000.00
AJAX.AS income_statement (annual, 2022-06-30) — Interest Income Non Operating: 464000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Interest Paid Cfo: -2131000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Interest Received Cfo: 114000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Inventory: 3909000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Invested Capital: 197636000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Investing Cash Flow: 6599000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 138482000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 138482000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Long Term Debt Payments: 0.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Long Term Equity Investment: 4928000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 2970000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Minority Interest: 0.00
AJAX.AS income_statement (annual, 2022-06-30) — Minority Interests: 0.00
AJAX.AS cash_flow (annual, 2022-06-30) — Net Business Purchase And Sale: 0.00
AJAX.AS income_statement (annual, 2022-06-30) — Net Income: -24320000.00
AJAX.AS income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -24320000.00
AJAX.AS income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -24320000.00
AJAX.AS income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -24320000.00
AJAX.AS income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -24320000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Net Income From Continuing Operations: -7573000.00
AJAX.AS income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -24320000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Net Intangibles Purchase And Sale: 323000.00
AJAX.AS income_statement (annual, 2022-06-30) — Net Interest Income: -2595000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Net Investment Purchase And Sale: 1213000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: 0.00
AJAX.AS cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: 0.00
AJAX.AS income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -2595000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Net Other Investing Changes: 8707000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Net PPE: 163022000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -3644000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 89353000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Non Current Deferred Taxes Assets: 8169000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Non Current Deferred Taxes Liabilities: 16752000.00
AJAX.AS income_statement (annual, 2022-06-30) — Normalized EBITDA: 42745000.00
AJAX.AS income_statement (annual, 2022-06-30) — Normalized Income: -22628672.00
AJAX.AS cash_flow (annual, 2022-06-30) — Operating Cash Flow: 3688000.00
AJAX.AS income_statement (annual, 2022-06-30) — Operating Income: -64648000.00
AJAX.AS income_statement (annual, 2022-06-30) — Operating Revenue: 184269000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 18333332.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Other Current Liabilities: 20685000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 108283000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Other Non Current Liabilities: 9446000.00
AJAX.AS income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 37768000.00
AJAX.AS income_statement (annual, 2022-06-30) — Other Operating Expenses: 26011000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Other Properties: 12709000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Other Receivables: 14959000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Other Short Term Investments: 22632000.00
AJAX.AS income_statement (annual, 2022-06-30) — Other Special Charges: -4000.00
AJAX.AS income_statement (annual, 2022-06-30) — Otherunder Preferred Stock Dividend: 0.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Payables: 38311000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 373000.00
AJAX.AS income_statement (annual, 2022-06-30) — Pretax Income: -31731000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Properties: 0.00
AJAX.AS cash_flow (annual, 2022-06-30) — Purchase Of Business: 0.00
AJAX.AS cash_flow (annual, 2022-06-30) — Purchase Of Intangibles: -159000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Purchase Of Investment: -809000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Purchase Of PPE: -3735000.00
AJAX.AS income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 18930000.00
AJAX.AS income_statement (annual, 2022-06-30) — Reconciled Depreciation: 12103000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Repayment Of Debt: 0.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Retained Earnings: -24320000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Sale Of Intangibles: 482000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Sale Of Investment: 2022000.00
AJAX.AS cash_flow (annual, 2022-06-30) — Sale Of PPE: 91000.00
AJAX.AS income_statement (annual, 2022-06-30) — Selling General And Administration: 24157000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Share Issued: 18333332.00
AJAX.AS income_statement (annual, 2022-06-30) — Special Income Charges: 4000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Stockholders Equity: 197636000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Tangible Book Value: 89353000.00
AJAX.AS income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: -516672.00
AJAX.AS income_statement (annual, 2022-06-30) — Tax Provision: -7411000.00
AJAX.AS income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.23
AJAX.AS cash_flow (annual, 2022-06-30) — Taxes Refund Paid: 105000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Total Assets: 463624000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Total Capitalization: 197636000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Total Debt: 145989000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 197636000.00
AJAX.AS income_statement (annual, 2022-06-30) — Total Expenses: 248917000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 265988000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 342199000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 172217000.00
AJAX.AS income_statement (annual, 2022-06-30) — Total Operating Income As Reported: -26876000.00
AJAX.AS income_statement (annual, 2022-06-30) — Total Other Finance Cost: -35000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Total Tax Payable: 9557000.00
AJAX.AS income_statement (annual, 2022-06-30) — Total Unusual Items: -2208000.00
AJAX.AS income_statement (annual, 2022-06-30) — Total Unusual Items Excluding Goodwill: -2208000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Tradeand Other Payables Non Current: 16983000.00
AJAX.AS balance_sheet (annual, 2022-06-30) — Working Capital: 27654000.00
AJAX.AS income_statement (annual, 2023-06-30) — +Operating Expense: 224498000.00
AJAX.AS income_statement (annual, 2023-06-30) — +Total Revenue: 188638000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Accounts Payable: 46658000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Accounts Receivable: 72558000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -37170000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Additional Paid In Capital: 101120000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Allowance For Doubtful Accounts Receivable: -4322000.00
AJAX.AS income_statement (annual, 2023-06-30) — Amortization: 49439000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Amortization Cash Flow: 669000.00
AJAX.AS income_statement (annual, 2023-06-30) — Basic Average Shares: 18333333.00
AJAX.AS income_statement (annual, 2023-06-30) — Basic EPS: 2.13
AJAX.AS cash_flow (annual, 2023-06-30) — Beginning Cash Position: 20380000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Buildings And Improvements: 137484000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Capital Expenditure: -3490000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 104924000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Capital Stock: 8250000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 11253000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 33696000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Cash Financial: 11253000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Change In Inventory: -3131000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Change In Other Current Liabilities: -2988000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Change In Receivables: -10642000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Change In Working Capital: -16761000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Changes In Cash: -9112000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Common Stock: 8250000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Common Stock Equity: 236609000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Construction In Progress: 4684000.00
AJAX.AS income_statement (annual, 2023-06-30) — Cost Of Revenue: 19280000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Current Assets: 146108000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 3942000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 3942000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Current Liabilities: 126679000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Depreciation: 9687000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Depreciation And Amortization: 10356000.00
AJAX.AS income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 59126000.00
AJAX.AS income_statement (annual, 2023-06-30) — Depreciation Income Statement: 9687000.00
AJAX.AS income_statement (annual, 2023-06-30) — Diluted Average Shares: 18333333.00
AJAX.AS income_statement (annual, 2023-06-30) — Diluted EPS: 2.13
AJAX.AS income_statement (annual, 2023-06-30) — Diluted NI Availto Com Stockholders: 38975000.00
AJAX.AS income_statement (annual, 2023-06-30) — EBIT: 59962000.00
AJAX.AS income_statement (annual, 2023-06-30) — EBITDA: 119088000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: -15000.00
AJAX.AS cash_flow (annual, 2023-06-30) — End Cash Position: 11253000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Financing Cash Flow: -5310000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Finished Goods: 7040000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Free Cash Flow: -20962000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Gain Loss On Sale Of Business: -9000.00
AJAX.AS income_statement (annual, 2023-06-30) — General And Administrative Expense: 19956000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 145743000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Gross Accounts Receivable: 76880000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Gross PPE: 158211000.00
AJAX.AS income_statement (annual, 2023-06-30) — Gross Profit: 169358000.00
AJAX.AS income_statement (annual, 2023-06-30) — Interest Expense: 4831000.00
AJAX.AS income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 4831000.00
AJAX.AS income_statement (annual, 2023-06-30) — Interest Income: 3962000.00
AJAX.AS income_statement (annual, 2023-06-30) — Interest Income Non Operating: 3962000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Interest Paid Cfo: -4859000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Interest Received Cfo: 162000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Inventory: 7040000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Invested Capital: 236609000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Investing Cash Flow: 13670000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 100982000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 100982000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Long Term Equity Investment: 5314000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 1824000.00
AJAX.AS income_statement (annual, 2023-06-30) — Net Income: 38975000.00
AJAX.AS income_statement (annual, 2023-06-30) — Net Income Common Stockholders: 38975000.00
AJAX.AS income_statement (annual, 2023-06-30) — Net Income Continuous Operations: 38975000.00
AJAX.AS income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: 38975000.00
AJAX.AS income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: 38975000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Net Income From Continuing Operations: -6361000.00
AJAX.AS income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: 38975000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Net Intangibles Purchase And Sale: 0.00
AJAX.AS income_statement (annual, 2023-06-30) — Net Interest Income: -6729000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: 1656000.00
AJAX.AS income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: -6729000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Net Other Investing Changes: 15504000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Net PPE: 121041000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -3490000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 90866000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Non Current Deferred Taxes Assets: 2283000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Non Current Deferred Taxes Liabilities: 21376000.00
AJAX.AS income_statement (annual, 2023-06-30) — Normalized EBITDA: 119634000.00
AJAX.AS income_statement (annual, 2023-06-30) — Normalized Income: 43524545.00
AJAX.AS cash_flow (annual, 2023-06-30) — Operating Cash Flow: -17472000.00
AJAX.AS income_statement (annual, 2023-06-30) — Operating Income: -55140000.00
AJAX.AS income_statement (annual, 2023-06-30) — Operating Revenue: 188638000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 18333333.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Other Current Liabilities: 28511000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 145743000.00
AJAX.AS income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 117203000.00
AJAX.AS income_statement (annual, 2023-06-30) — Other Operating Expenses: 34615000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Other Payable: 35641000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Other Properties: 14219000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Other Receivables: 32814000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 22443000.00
AJAX.AS income_statement (annual, 2023-06-30) — Other Special Charges: -9000.00
AJAX.AS income_statement (annual, 2023-06-30) — Otherunder Preferred Stock Dividend: 0.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Payables: 93265000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 426000.00
AJAX.AS income_statement (annual, 2023-06-30) — Pretax Income: 55131000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Properties: 0.00
AJAX.AS cash_flow (annual, 2023-06-30) — Purchase Of Intangibles: 0.00
AJAX.AS cash_flow (annual, 2023-06-30) — Purchase Of Investment: -366000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Purchase Of PPE: -3490000.00
AJAX.AS income_statement (annual, 2023-06-30) — Reconciled Cost Of Revenue: 19280000.00
AJAX.AS income_statement (annual, 2023-06-30) — Reconciled Depreciation: 10356000.00
AJAX.AS balance_sheet (annual, 2023-06-30) — Retained Earnings: 38975000.00
AJAX.AS cash_flow (annual, 2023-06-30) — Sale Of Intangibles: 0.00